Published in Gene Therapy Weekly, October 11th, 2001
In the studies, performed with laboratory mice, two different genes that were separately injected into the tail veins or eyes of the animals reduced new blood vessel growth by up to 90%. One gene is for endostatin, which inhibits blood vessel growth; the other is a substance that increases cell survival. The mice had conditions similar to macular degeneration and diabetic retinopathy, the leading causes of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.